CDSCO to create forum to discuss “various issues” pertaining to drug regulations
India’s apex drug regulator has decided to constitute a forum for its chief to meet pharma associations regularly as part of efforts to improve ease of doing business for the…
KSPC initiative to aware people not to buy medicines from unqualified persons at drugstores
Karnataka State Pharmacy Council (KSPC) now approaching Print & TV advt campaign to highlight the dangers of selling drugs by unqualified persons at drug stores. Public awareness is necessary and…
Insomnia, can be generic as reports showed is linked to specific DNA mutations
Thinking that it’s hard to sleep? Accuse your qualities, say specialists, who recognized particular generic components that may trigger the advancement of sleep issues. The discoveries built up that a…
Cancer: Use of Antibiotics & New Therapies
According to WHO, “Cancer is the second leading cause of death globally, and was responsible for 8.8 million deaths in 2015. Globally, nearly 1 in 6 deaths is due to…
“Modicare” – World’s Biggest Healthcare Program
The biggest take away from Union Budget 2018 presented by Finance Minister ArunJaitley is unveiling of mega National Health Protection Scheme (NHPS) dubbed as Modicare. This is being claimed to…
Are ‘functional food’ are really functional? Know what expert has to say…
Functional Foods Different experts define functional food differently however, as per their generally accepted definition, the food that is capable of reducing the risk of chronic disease and hence providing…
ChrysCap backs Curatio in latest pharma bet
Mumbai: ChrysCapital will buy a significant minority stake in Curatio Healthcare, an emerging dermatology products maker, marking its tenth investment in the Indian pharmaceutical sector. The country’s largest private equity…
Lupin signs research pact with CSIR-NCL, Dept of Science &Tech
Mumbai: Pharma major Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous purification process…
Price crash ahead Key diabetes cancer drugs to go off patent in India
The next three to five years would see some key cardiovascular, diabetic and oncology molecules going off-patent in the Indian market. This could trigger launches of generic versions by local…